Article ID Journal Published Year Pages File Type
2872063 The Annals of Thoracic Surgery 2014 6 Pages PDF
Abstract
Complete national data do not support the widespread assumption that adjuvant chemotherapy compliance is superior after thoracoscopic lobectomy for NSCLC. Instead, significant predictors of chemotherapy compliance are patient's age, comorbidity, and pathologic N status.
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Preview
Adjuvant Chemotherapy Compliance Is Not Superior After Thoracoscopic Lobectomy
Authors
, , , , , ,